Breast Cancer News and Research

Latest Breast Cancer News and Research

Study sheds light on fertility concerns of young breast cancer patients

Concerns about fertility kept a third of young women with breast cancer from taking tamoxifen, despite its known benefit in reducing the risk of breast cancer coming back.

25 Aug 2015

Mayo Clinic scientists discover potential way to reprogram cancer cells back to normalcy

Cancer researchers dream of the day they can force tumor cells to morph back to the normal cells they once were. Now, researchers on Mayo Clinic's Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.

25 Aug 2015

Karolinska Institutet study may lead to development of better immune-based cancer therapies

A study by researchers at Sweden's Karolinska Institutet is the first to suggest that cells in the tumour blood vessels contribute to a local environment that protects the cancer cells from tumour-killing immune cells. The results, which are being published in the 'Journal of the National Cancer Institute', can contribute to the development of better immune-based cancer therapies.

25 Aug 2015

Veritas Genetics obtains CE mark approval for myBRCA genetic screening test

Boston-based Veritas Genetics, a pioneer in accessible genetic screening for disease prevention and early detection, received its first European CE mark approval for the company's hereditary breast and ovarian cancer genetic screening test, myBRCA. Veritas introduced myBRCA, which sequences BRCA1 and BRCA2 genes using proprietary gene-targeting technology and Next Generation Sequencing, in North America in May 2015.

25 Aug 2015

Regen BioPharma implements gene silencing technology in killing cancer stem cells

Regen BioPharma Inc. reported today the successful implementation of its gene silencing technology, covered by patent # 8,263,571, in killing cancer stem cells.

24 Aug 2015

Esperance, MD Anderson form strategic alliance to accelerate development of anti-cancer candidate EP-100

Esperance Pharmaceuticals Inc. today announced that it has entered into a strategic alliance agreement with MD Anderson Cancer Center to accelerate the clinical development of its lead anti-cancer candidate EP-100 for the treatment of ovarian cancer and to collaborate on preclinical studies of EP-100 as a treatment for breast cancer.

24 Aug 2015

Low rate of mortality from breast cancer after DCIS diagnosis

Research published this week estimates that the risk of dying from early stage breast cancer within 20 years of diagnosis is very low (3.3%).

21 Aug 2015

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Women diagnosed with ductal carcinoma in situ (DCIS) are twice as likely to die from breast cancer compared to the general U.S. population, according to a new study led by Dr. Steven Narod.

21 Aug 2015

Low, moderate alcohol intake elevates women’s risk of alcohol-related cancers

Low to moderate alcohol consumption is linked to an increased risk of alcohol-related cancers in women, but not men, who have never smoked, research suggests.

20 Aug 2015

EnGeneIC begins Phase 1 Tailored-EDV trial for advanced solid tumor

EnGeneIC Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the first patient has been dosed in its Phase 1 Tailored-EDV trial. The trial is being conducted at the Northern Cancer Institute in Sydney, Australia.

19 Aug 2015

Researchers refine breast cancer risk model to give more accurate assessment

A national risk model that gauges a woman's chance of developing breast cancer has been refined to give a more accurate assessment. The revised figures, based on data from more than one million patients, reveal a 300 percent increase in a subset of women whose five-year risk is estimated at 3 percent or higher.

19 Aug 2015

TapImmune announces successful conveyance of Investigational New Drug Application from Mayo Clinic

TapImmune, Inc., a clinical stage immunotherapy company, specializing in the development of innovative technologies for the treatment of metastatic cancer, announced today the successful conveyance of the Mayo Clinic IND (Investigational New Drug Application) to TapImmune as part of the recently completed licensing agreement.

18 Aug 2015

First patient enrolled in Phase II trial of ImmunoPulse IL-12 and pembrolizumab combination therapy

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced enrollment of the first patient into the Phase II Investigator Sponsored Trial led by the University of California, San Francisco to assess the anti-tumor activity, safety, and tolerability of the combination of OncoSec's investigational therapy, ImmunoPulse IL-12, and Merck's approved anti-PD-1 agent, KEYTRUDA (pembrolizumab), in patients with unresectable metastatic melanoma.

18 Aug 2015

Music therapy reduces anxiety in women undergoing surgical breast biopsies

A first-of-its-kind study published in the Journal of Clinical Oncology finds that music therapy lessened anxiety for women undergoing surgical breast biopsies for cancer diagnosis and treatment.

18 Aug 2015

Mayo Clinic study highlights LumaGEM MBI as cost-effective tool for detecting women with dense breast tissue

A recent study conducted by Mayo Clinic has determined that the addition of Molecular Breast Imaging (MBI) for women with dense breast tissue resulted in a lower cost per cancer detected than screening with mammography alone.

17 Aug 2015

Kentucky researcher awarded NCI grant to study potential link between obesity and breast cancer

The National Cancer Institute recently awarded a $750,000 grant to University of Kentucky researcher Fredrick Onono to study the potential link between obesity and breast cancer.

14 Aug 2015

Swarm intelligence can help to improve breast cancer screening

Breast cancer is the most frequent type of cancer in women and currently accounts for 29% of all new cancer cases in the U.S. Wide-ranging mammography screening programs have been set up for early diagnosis. However, even if two physicians assess the x-rays, which is the usual procedure in Europe, this often leads to wrong decisions: about 20% of patients with cancer are diagnosed as being cancer-free, whereas about 20% of cancer-free patients are diagnosed with cancer.

13 Aug 2015

Researchers reveal cellular origin of PIK3CA-induced breast tumors

In a study published in Nature, researchers lead by Cédric Blanpain, MD/PhD, WELBIO investigator and Professor at the Université libre de Bruxelles, Belgium, in collaboration with Pr Wayne Phillips, Australia and Pr Christos Sotiriou, Bordet Institute, Belgium, uncovered the cellular origin of PIK3CA-induced breast tumors and demonstrated that the cancer cell of origin controls tumor heterogeneity and is associated with different breast tumors types and clinical prognosis.

13 Aug 2015

USF Health, FORCE receive $1.45 million from PCORI to advance and expand clinical research network

A team led by the University of South Florida Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered) received a $1.45-million funding award for a three-year project from the Patient-Centered Outcomes Research Institute to continue to advance and expand the ABOUT Network as part of the second phase of PCORnet: the National Patient-Centered Clinical Research Network.

13 Aug 2015

New MRI contrast agent detects tiny breast cancer tumors, micrometastases

Researchers at Case Western Reserve University have developed a magnetic resonance imaging (MRI) contrast agent that detects much smaller aggressive breast cancer tumors and micrometastases than current agents can identify.

13 Aug 2015

Breast Cancer News and Research

Latest Breast Cancer News and Research

Study sheds light on fertility concerns of young breast cancer patients

Mayo Clinic scientists discover potential way to reprogram cancer cells back to normalcy

Karolinska Institutet study may lead to development of better immune-based cancer therapies

Veritas Genetics obtains CE mark approval for myBRCA genetic screening test

Regen BioPharma implements gene silencing technology in killing cancer stem cells

Esperance, MD Anderson form strategic alliance to accelerate development of anti-cancer candidate EP-100

Low rate of mortality from breast cancer after DCIS diagnosis

Women diagnosed with ductal carcinoma in situ more likely to die from breast cancer

Low, moderate alcohol intake elevates women’s risk of alcohol-related cancers

EnGeneIC begins Phase 1 Tailored-EDV trial for advanced solid tumor

Researchers refine breast cancer risk model to give more accurate assessment

TapImmune announces successful conveyance of Investigational New Drug Application from Mayo Clinic

First patient enrolled in Phase II trial of ImmunoPulse IL-12 and pembrolizumab combination therapy

Music therapy reduces anxiety in women undergoing surgical breast biopsies

Mayo Clinic study highlights LumaGEM MBI as cost-effective tool for detecting women with dense breast tissue

Kentucky researcher awarded NCI grant to study potential link between obesity and breast cancer

Swarm intelligence can help to improve breast cancer screening

Researchers reveal cellular origin of PIK3CA-induced breast tumors

USF Health, FORCE receive $1.45 million from PCORI to advance and expand clinical research network

New MRI contrast agent detects tiny breast cancer tumors, micrometastases

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Breast Cancer News and Research

Latest Breast Cancer News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in